Diabetes has reached epidemic proportions, and the cardiovascular complications of diabetes are life-threatening and disabling. This book is unique in providing a simple explanation of the biochemical role of PKC in diabetes complications, which allows clinicians to understand why PKC inhibitors (in development) are an exciting prospect for future treatment to slow progression of eye & foot complications. New features of this Second Edition include: Updated throughout to reflect the impact of recent major clinical trials on current clinical practice Includes a major new section on diabetic neuropathy Revised section on diabetic retinopathy Each chapter is short and succinct, focusing on ‘best practice’. There are key learning points at the end of each chapter, with numerous helpful tables, figures and clinical images.